Katherine is an Investment Professional with Hadean Ventures, responsible for deal sourcing, due diligence and management of active investments

Healthcare Associate, Investment Banking

• Analysing women’s health landscape for acquisition targets and licensing assets, assessing their commercial potential and strategic fit and leading preliminary due diligence• Sizing market opportunity, conducting expert interviews and building business case for fertility medical device opportunity to support Theramex and CVC investment committee decision

Healthcare & Consumer M&A• Valued potential mid-cap acquisition targets for a multi-national pharmaceutical company, analysing takeover premia and deal structures for companies with strong strategic fit• Coordinated sale process of £2bn+ consumer product division, identifying likely buyers, preparing marketing materials, and conducting valuation work for sell-side due diligence• Evaluated market landscape, commercial potential and preliminary valuation for midcap ophthalmology medtech, aligning with the founder on exit strategies and buyer universe

• Specialize in forecasting, pipeline portfolio development, asset identification/ due diligence, payer contracting/managed markets, market research, and commercial strategy within the pharmaceutical industry • Developed business case and launch strategy for first HIV-preventative medication: delivered long-range sales projections, developed sales and marketing budgets, and set go-to-market strategy for patients, physicians, and insurers; launch sales exceeded projections by 10%• Collaborated closely with Partners and Directors on business development and pitch organisation• Manage and mentor a team of onshore and offshore associates and devised a knowledge sharing platform across the client engagement team (business consulting, operations, and technology teams)

• Created Excel risk-adjusted forecasting and Monte Carlo simulation models to shape R&D investment decisions for early-stage therapies; 80% budget allocated to priority projects• Optimised pricing models and analysed insurance claim databases to influence health insurer contracts; achieved key account gross-to-net improvements of 3-6% • Performed primary market research to inform ongoing promotional strategy and interfaced with marketing agency to direct tactical implementation; attained average 200% ROI across marketing campaigns for Hepatitis C therapies

• Spearheaded research project with surgeons and medical physicists to 3D-print personalized applicators to provide targeted radiation for patients with prostate or gynaecological cancers• Oversaw treatment of three patients with first 3D-printed brachytherapy applicators; achieved better tumour proximity and patient comfort, no disease recurrences at 6-month follow-up, and over 10x reduction in applicator device cost • Published two research articles as 2nd and 3rd author in national journal publications; presented research at 2014 American Brachytherapy Society Annual MeetingPublications: o https://www.ncbi.nlm.nih.gov/pubmed/25679174 o https://www.ncbi.nlm.nih.gov/pubmed/27504130

• Managed SAP data and intranet portal conversions for the PG&E Pension Co-Sourcing Project from initial assessment to Go Live date• Conducted unit and scenario testing of in-house development systems and managed client relations

Study stem cells, cancer cells, and growth proteins for application in tissue and organ regenerationPerform immunofluorescence staining and cell imaging using AxioVision software